Cargando…

Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer

BACKGROUND: Cancer-testis antigens (CTAs) are often expressed in tumor and testicular tissues but not in other normal tissues. To date, there has been no comprehensive study of the expression and clinical significance of CTA genes associated with endometrial cancer (EC) development. Additionally, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miao, Yu, Konno, Yosuke, Wang, Baojin, Zhu, Lin, Zhai, Tianyue, Ihira, Kei, Kobayashi, Noriko, Watari, Hidemichi, Jin, Xin, Yue, Junming, Dong, Peixin, Fang, Mingyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960418/ https://www.ncbi.nlm.nih.gov/pubmed/36829176 http://dx.doi.org/10.1186/s12967-023-03998-8

Ejemplares similares

Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway
por: Dong, Peixin, et al.
Publicado: (2021)

MicroRNA-361-Mediated Inhibition of HSP90 Expression and EMT in Cervical Cancer Is Counteracted by Oncogenic lncRNA NEAT1
por: Xu, Daozhi, et al.
Publicado: (2020)

Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes
por: Dong, Peixin, et al.
Publicado: (2019)

Long Non-Coding RNA TMPO-AS1 Promotes GLUT1-Mediated Glycolysis and Paclitaxel Resistance in Endometrial Cancer Cells by Interacting With miR-140 and miR-143
por: Dong, Peixin, et al.
Publicado: (2022)

Critical Roles of PIWIL1 in Human Tumors: Expression, Functions, Mechanisms, and Potential Clinical Implications
por: Dong, Peixin, et al.
Publicado: (2021)

PD-L1 Is a Tumor Suppressor in Aggressive Endometrial Cancer Cells and Its Expression Is Regulated by miR-216a and lncRNA MEG3
por: Xu, Daozhi, et al.
Publicado: (2020)

MicroRNA-361: A Multifaceted Player Regulating Tumor Aggressiveness and Tumor Microenvironment Formation
por: Xu, Daozhi, et al.
Publicado: (2019)

The Expression, Functions and Mechanisms of Circular RNAs in Gynecological Cancers
por: Dong, Peixin, et al.
Publicado: (2020)

MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells
por: Dong, Peixin, et al.
Publicado: (2016)

Emerging Therapeutic Biomarkers in Endometrial Cancer
por: Dong, Peixin, et al.
Publicado: (2013)

EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis
por: Ihira, Kei, et al.
Publicado: (2017)

Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124
por: Dong, Peixin, et al.
Publicado: (2016)

Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression
por: Dong, Peixin, et al.
Publicado: (2016)

Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges
por: Dong, Peixin, et al.
Publicado: (2019)

The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer
por: Dong, Peixin, et al.
Publicado: (2014)

A Luminacin D Analog HL142 Inhibits Ovarian Tumor Growth and Metastasis by Reversing EMT and Attenuating the TGFβ and FAK Pathways
por: Wang, Baojin, et al.
Publicado: (2021)

miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation
por: Dong, Peixin, et al.
Publicado: (2018)

Long Non-coding RNA NEAT1: A Novel Target for Diagnosis and Therapy in Human Tumors
por: Dong, Peixin, et al.
Publicado: (2018)

Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments
por: Mitamura, Takashi, et al.
Publicado: (2014)

Multivariate survival analysis of the patients with recurrent endometrial cancer
por: Odagiri, Tetsuji, et al.
Publicado: (2011)

iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling
por: Xiong, Ying, et al.
Publicado: (2017)

Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors
por: Dong, Peixin, et al.
Publicado: (2015)

The prognosis of endometrial cancers stratified with conventional risk factors and modified molecular classification
por: Yamazaki, Hiroyuki, et al.
Publicado: (2022)

TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer
por: Yang, Qiannan, et al.
Publicado: (2020)

MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells
por: Konno, Yosuke, et al.
Publicado: (2014)

Musashi-2, a novel oncoprotein promoting cervical cancer cell growth and invasion, is negatively regulated by p53-induced miR-143 and miR-107 activation
por: Dong, Peixin, et al.
Publicado: (2017)

B7H3 As a Promoter of Metastasis and Promising Therapeutic Target
por: Dong, Peixin, et al.
Publicado: (2018)

Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
por: Dong, Peixin, et al.
Publicado: (2018)

miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway
por: Wang, Baojin, et al.
Publicado: (2018)

MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1
por: Dong, Peixin, et al.
Publicado: (2011)

Cryptotanshinone inhibits ovarian tumor growth and metastasis by degrading c-Myc and attenuating the FAK signaling pathway
por: Guo, Huijun, et al.
Publicado: (2022)

Nerve-sparing radical hysterectomy in the precision surgery for cervical cancer
por: Sakuragi, Noriaki, et al.
Publicado: (2020)

Lymphadenectomy issues in endometrial cancer
por: Konno, Yosuke, et al.
Publicado: (2021)

EIF5A2 controls ovarian tumor growth and metastasis by promoting epithelial to mesenchymal transition via the TGFβ pathway
por: Zhao, Guannan, et al.
Publicado: (2021)

Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study
por: Zhai, Tianyue, et al.
Publicado: (2023)

Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells
por: Zhao, Guannan, et al.
Publicado: (2017)

Germline PRDM1 Variant rs2185379 in Long-Term Recurrence-Free Survivors of Advanced Ovarian Cancer
por: Mitamura, Takashi, et al.
Publicado: (2022)

Molecular basis underlying resistance to Mps1/TTK inhibitors
por: Koch, A, et al.
Publicado: (2016)

Evaluation of TTK Chitra heart valve prosthesis in pediatric patients
por: Varma, Praveen Kerala, et al.
Publicado: (2022)

Therapeutic targeting of the TPX2/TTK network in colorectal cancer
por: Shaath, Hibah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_st9jns7kmvl368nq7d0p8d4im9